π¬Deep Research
GLMD β Galmed Pharmaceuticals Ltd Β· catalysts, narrative & risks
Galmed Pharmaceuticals Ltd. (ticker: GLMD β EOCN) β Research Note
Important context on identity: As of the current date (2026-11-01), Galmed Pharmaceuticals is trading under the new name Eocene Ltd. and ticker EOCN, after announcing the rebranding on September 9, 2026 [1], [4], [10]. The legacy ticker GLMD is effectively retired: Yahoo Finance's symbol lookup returns no results for "GLMD" [9], and SEC filing trackers now list the issuer as EOCN [11]. I treat GLMD and EOCN as the same security for the remainder of this note.
1. Recent Catalysts (roughly AugustβOctober 2026)
AI-assisted research from the K3vl4r desk β not personalized investment advice. More research β